Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. South Africa
  4. Johannesburg Stock Exchange
  5. Aspen Pharmacare Holdings Limited
  6. News
  7. Summary
    APN   ZAE000066692

ASPEN PHARMACARE HOLDINGS LIMITED

(APN)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Aspen Pharmacare : welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site

11/24/2021 | 11:10am EST

Gqeberha, South Africa - Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha.

President Kenyatta's visit to Aspen forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa's dependence on pharmaceutical importers and to strengthen the continent's capacity to address its own public health needs.

During his visit President Kenyatta witnessed Aspen's technical capacity to manufacture and distribute human vaccines for a global market in accordance with international standards and discussed areas of possible cooperation between Aspen and Kenya.

Stephen Saad, Aspen Group Chief Executive said, "The COVID-19 pandemic has demonstrated dependence on non-African suppliers to meet African healthcare needs. Aspen is providing a local solution to this need and is committed to working together with Kenyan authorities and their counterparts in strengthening pharmaceutical and health security on the continent. The answer to equitable access to vaccines and other critical lifesaving medicines is to capacitate Af­­rica to serve its own people. Aspen has been able to assist in achieving this goal through the manufacturing capabilities that exist at our sterile manufacturing facility in Gqeberha. It is, for the sake of health security and sustainability, critical that African countries collaborate locally and with the international community to ensure security of demand, underwritten through long-term committed offtakes, and the facilitation of technology licenses and transfers."

Presidents Cyril Ramaphosa and Uhuru Kenyatta met in Pretoria on 23 November 2021 at which time they discussed the latest developments around the global response to the COVID-19 pandemic, including the important matter of vaccine manufacturing and distribution. They reaffirmed their call for the fair and equitable distribution of vaccines.

Disclaimer

Aspen Pharmacare Holdings Ltd. published this content on 24 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 16:09:07 UTC.


ę Publicnow 2021
All news about ASPEN PHARMACARE HOLDINGS LIMITED
01/20Dozens of firms to make cheap version of Merck COVID pill for poorer nations
RE
01/18ASPEN PHARMACARE : Business update for the six months ended 31 December 2021 and withdrawa..
PU
2021ASPEN PHARMACARE HOLDINGS LIMITED : Proxy Statments
CO
2021ASPEN PHARMACARE : Report on Annual General Meeting proceedings
PU
2021Africans Will Get Wider Access to Vaccines in New Distribution Deal
AQ
2021Aspen confirms non-binding term sheet on manufacture and sale of an aspen branded covid..
AQ
2021S.Africa's Aspen signs deal paving way for J&J COVID vaccine licence
RE
2021South Africa's rand finds support in weaker dollar, stocks firm
RE
2021African Union calls for Aspen-J&J deal to include substance production
RE
2021Johnson & Johnson Units, Aspen Pharmacare Sign Term Sheet for Manufacturing of COVID-19..
MT
More news
Financials
Sales 2022 40 969 M 2 651 M 2 651 M
Net income 2022 6 580 M 426 M 426 M
Net Debt 2022 13 884 M 898 M 898 M
P/E ratio 2022 14,2x
Yield 2022 1,43%
Capitalization 93 536 M 6 066 M 6 053 M
EV / Sales 2022 2,62x
EV / Sales 2023 2,38x
Nbr of Employees 8 844
Free-Float -
Chart ASPEN PHARMACARE HOLDINGS LIMITED
Duration : Period :
Aspen Pharmacare Holdings Limited Technical Analysis Chart | APN | ZAE000066692 | MarketScreener
Technical analysis trends ASPEN PHARMACARE HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 205,00 ZAR
Average target price 263,00 ZAR
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Sean Matthew Capazorio Group Finance Officer & Executive Director
Kuseni Douglas Dlamini Chairman
Lorraine Angela Hill Group Operating Officer
Babalwa Ngonyama Independent Non-Executive Director